Neuroprotection or neurotoxicity? new insights into the effects of Acanthopanax senticosus harms on nervous system through cerebral metabolomics analysis.

ETHNOPHARMACOLOGICAL RELEVANCE Acanthopanax senticosus harms (AS), also called "Ciwujia" in Chinese and "Siberian ginseng" in the Siberian Taiga region, is the herb used in traditional medicinal systems in China and Russia, which has been applied to the treatment of various nervous and cerebrovascular diseases, such as depression, mental fatigue, and transient global cerebral ischemia. The previous research works usually tended to focus on the neuroprotective effects of AS, but ignored its additional effects that are not entirely beneficial to the nervous system. Therefore, to discover the potential intervention targets of AS and evaluate their roles in the nervous system are the urgent problems. MATERIALS AND METHODS Ultra-performance liquid chromatography-quadrupole time-of-flight-mass spectrometry (UPLC-QTOF-MS) coupled with pattern recognition methods were integrated to investigate the metabolic profiles of AS-treated rats. The analysis of possible pathways influenced by AS was performed by ingenuity pathway analysis (IPA) with MetPA. RESULTS Treated with AS, 16 modulated metabolites were identified and considered as the potential intervention targets of AS, out of which 3 metabolites had protective effects on the nervous system, whereas 7 metabolites showed the neurotoxicity. CONCLUSION These results may reveal that the effects of AS on nervous system had two sides, and it could not only exert the neuroprotection but also produce some potential neurotoxicity.

[1]  M. Baumgartner,et al.  Pipecolic acid as a diagnostic marker of pyridoxine-dependent epilepsy. , 2005, Neuropediatrics.

[2]  M. Ikekita,et al.  Phytosphingosine induced mitochondria‐involved apoptosis , 2005, Cancer science.

[3]  M. Hattori,et al.  Active components from Siberian ginseng (Eleutherococcus senticosus) for protection of amyloid β(25–35)-induced neuritic atrophy in cultured rat cortical neurons , 2011, Journal of Natural Medicines.

[4]  Shu-min Liu,et al.  Cerebral metabonomics study on Parkinson's disease mice treated with extract of Acanthopanax senticosus harms. , 2013, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[5]  G. Rishton,et al.  Natural products as a robust source of new drugs and drug leads: past successes and present day issues. , 2008, The American journal of cardiology.

[6]  Véronique Paban,et al.  Age‐related changes in metabolic profiles of rat hippocampus and cortices , 2010, The European journal of neuroscience.

[7]  Alok Kumar,et al.  Cell death mechanisms in the early stages of acute glutamate neurotoxicity , 2010, Neuroscience Research.

[8]  Xiaodong Cheng,et al.  Cyclic AMP sensor EPAC proteins and energy homeostasis , 2014, Trends in Endocrinology & Metabolism.

[9]  C. Dutra-filho,et al.  Pipecolic acid induces oxidative stress in vitro in cerebral cortex of young rats and the protective role of lipoic acid , 2014, Metabolic Brain Disease.

[10]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[11]  V. Felipo,et al.  Increasing the function of the glutamate‐nitric oxide‐cyclic guanosine monophosphate pathway increases the ability to learn a Y‐maze task , 2009, Journal of neuroscience research.

[12]  Mi-Yeon Kim,et al.  Neuroprotective effects of Eleutherococcus senticosus bark on transient global cerebral ischemia in rats. , 2012, Journal of ethnopharmacology.

[13]  Shu-min Liu,et al.  Protective effect of extract of Acanthopanax senticosus Harms on dopaminergic neurons in Parkinson's disease mice. , 2012, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[14]  Thomas Werge,et al.  Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models. , 2013, Antioxidants & redox signaling.

[15]  A. Scherz,et al.  Ablation of Ceramide Synthase 2 Causes Chronic Oxidative Stress Due to Disruption of the Mitochondrial Respiratory Chain* , 2013, The Journal of Biological Chemistry.

[16]  I. Izquierdo,et al.  Hippocampal cGMP and cAMP are differentially involved in memory processing of inhibitory avoidance learning , 1996, Neuroreport.

[17]  Shu-min Liu,et al.  Neuroprotective effects of extract of Acanthopanax senticosus harms on SH-SY5Y cells overexpressing wild-type or A53T mutant α-synuclein. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[18]  Xiaoyu Li,et al.  Protective effects of aqueous extract from Acanthopanax senticosus against corticosterone-induced neurotoxicity in PC12 cells. , 2013, Journal of ethnopharmacology.

[19]  V. Felipo,et al.  Long-Term Potentiation in Hippocampus Involves Sequential Activation of Soluble Guanylate Cyclase, cGMP-Dependent Protein Kinase, and cGMP-Degrading Phosphodiesterase , 2002, The Journal of Neuroscience.

[20]  P. Shaw,et al.  Anti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models? , 2012, Journal of ethnopharmacology.

[21]  Dan Gao,et al.  Metabonomic study on the antitumor effect of flavonoid derivative 3d in HepG2 cells and its action mechanism. , 2014, Talanta.

[22]  A. Larsson,et al.  Inborn errors in the metabolism of glutathione , 2007, Orphanet journal of rare diseases.

[23]  Shu-min Liu,et al.  Recent advances in herbal medicines treating Parkinson's disease. , 2013, Fitoterapia.

[24]  P. Formánek,et al.  Significance of the natural occurrence of L- versus D-pipecolic acid: a review. , 2013, Chirality.

[25]  V. Felipo,et al.  Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications , 2010, Metabolic Brain Disease.

[26]  I. Izquierdo,et al.  Further evidence for the involvement of a hippocampal cGMP/cGMP‐dependent protein kinase cascade in memory consolidation , 1997, Neuroreport.

[27]  A. Blokland,et al.  The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP Levels in hippocampal slices , 2005, Behavioural Brain Research.

[28]  Y. Vives-Gilabert,et al.  Hippocampal dysfunction in cured Cushing's syndrome patients, detected by 1H‐MR‐spectroscopy , 2013, Clinical endocrinology.

[29]  Ying-yong Zhao,et al.  Effect of ergosta-4,6,8(14),22-tetraen-3-one (ergone) on adenine-induced chronic renal failure rat: a serum metabonomic study based on ultra performance liquid chromatography/high-sensitivity mass spectrometry coupled with MassLynx i-FIT algorithm. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[30]  R. Dringen,et al.  Metabolism and functions of glutathione in brain , 2000, Progress in Neurobiology.

[31]  L. Qin,et al.  Bioactivity-guided fractionation for anti-fatigue property of Acanthopanax senticosus. , 2011, Journal of ethnopharmacology.

[32]  S. M. Rates,et al.  Plants as source of drugs. , 2001, Toxicon : official journal of the International Society on Toxinology.

[33]  J. Reynolds,et al.  A novel nitrate ester reverses the cognitive impairment caused by scopolamine in the Morris water maze , 2000, Neuroreport.

[34]  Shu-min Liu,et al.  Urinary metabonomics study on toxicity biomarker discovery in rats treated with Xanthii Fructus. , 2013, Journal of ethnopharmacology.